Grasping Epidemic Prevention Step by Step, Promoting Production in a Link
——Interview with Zhao Chunjian, General Manager of Zhejiang Cheng Yi Pharmaceutical Co., Ltd
On March 16th, Chen Weijun, a member of the Standing Committee of the Zhejiang Provincial Party Committee and Secretary of the Wenzhou Municipal Party Committee, announced on behalf of Wenzhou City that the "Marine Biopharmaceutical Manufacturing Project" of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was officially put into operation at the "Zhejiang Provincial High Quality Development Video Conference". As the only representative of this year's advanced manufacturing project in Wenzhou, this project marks a new level of development for Cheng Yi Pharmaceutical. After the meeting, Zhao Chunjian, the general manager of the company, gave an exclusive interview to a reporter from Volkswagen Securities News on how to "focus on epidemic prevention and production at the same time".
Reporter: The official launch of the "Marine Biomedical Manufacturing Project" can be said to be a landmark event in the development history of Cheng Yi Pharmaceutical, and many investors are very concerned about the development process of this project.
Zhao Chunjian: Cheng Yi Pharmaceutical's "Marine Biopharmaceutical Manufacturing Project" was listed as the second batch of major industrial projects in the province by the Zhejiang Provincial Development and Reform Commission and the Provincial Department of Natural Resources at the end of December 2019. This project, also known as the "Cheng Yi Pharmaceutical Health Industrial Park" in Wenzhou, covers a total land area of over 120 acres with a total investment of nearly 500 million yuan. It mainly includes a research and development center, preparation building, elevated warehouse, and ancillary facilities, totaling 60000 square meters. The project started construction in January 2018 and was basically completed within two years. It has received widespread attention from all sectors of society due to its creation of "Cheng Yi Construction Speed" and "Reform Acceleration of Up to One Run" in Dongtou District.
Reporter: This year's unprecedented epidemic has brought enormous pressure to the production and operation of many enterprises. How does Cheng Yi Pharmaceutical seek a balance between epidemic prevention and production? Ensure both epidemic prevention and production are in place.
Zhao Chunjian: Since 2017, as the first listed marine biopharmaceutical enterprise in Zhejiang Province, Cheng Yi Pharmaceutical has accelerated its transformation and upgrading. It has successfully gone public and moved its research and development, marketing, and securities centers to Hongqiao, Shanghai, taking the lead in integrating into the "Yangtze River Delta" and opening the "front store and back factory" model, achieving a significant leap from "offshore" to "Shanghai". At the beginning of this year, facing the sudden outbreak of the epidemic, Cheng Yi Pharmaceutical actively responded to the call of the Provincial Party Committee, Provincial Government, and Municipal Party Committee and Municipal Government, and began working overtime on January 27th to produce materials related to the aid to Wuhan; While actively fighting the epidemic prevention and control war, we organize production and sales in a "interlocking manner". The company fully resumed work on February 18th, with an employee attendance rate of over 95%. On the 20th, the company donated 1.01 million yuan worth of anti epidemic materials to the anti epidemic front line (including 600000 yuan in cash donated to the Zhejiang Charity Federation, and 410000 yuan worth of ribavirin injection and capsules donated to the Hubei Red Cross and major hospitals). At the same time, it also mobilized party members and middle-level cadres from Guangzhou University to donate to the anti epidemic front line, effectively fulfilling social responsibilities. Since the comprehensive resumption of work, the company has worked overtime and produced at full capacity, fully completing the 2020 production and operation plan tasks.
On the morning of March 11th, Chen Weijun, a member of the Standing Committee of the Zhejiang Provincial Party Committee and Secretary of the Wenzhou Municipal Party Committee, came to Cheng Yi Pharmaceutical to conduct a special research mission with the "Three Strong and Two Promotions" special activity. Secretary Chen Weijun fully affirmed Cheng Yi Pharmaceutical's experience in preventing and combating epidemics, as well as its resumption of work and production. He encouraged enterprises to deeply cultivate the big health industry, promote further improvement of quality and efficiency, and urged the local government to "strongly support and serve good enterprises and products to the end
Since the outbreak of COVID-19, Cheng Yi Pharmaceutical has adhered to the principle of "two hands, both hands must be hard", and has taken strong measures to prevent and combat the epidemic. At the same time, it has resumed work as soon as possible, closely monitored production, and ensured sales. We are well aware that epidemic prevention is related to the health of employees, and production is related to the development of enterprises. The two cannot be neglected. Our experience is to follow closely in epidemic prevention and production, and to achieve early mobilization and deployment.
One is to deploy this year's work as soon as possible. In January before the outbreak of the epidemic, the company had already held a "closed door meeting" of the 2020 production and operation plan, as well as a meeting of all employees in quality, safety, and environmental protection, to deploy and implement the various goals and tasks set by the board of directors for 2020. On the morning of January 21st, the company held the "Annual Work Reporting Conference" for middle-level cadres and above, with more than 30 key personnel taking the stage to address shortcomings, identify gaps, and demonstrate determination. It can be said that before the outbreak of the epidemic, the company's various tasks were already deployed in 2020.
The second is to initiate epidemic prevention and control work as soon as possible. On the afternoon of January 23rd, the People's Government of Zhejiang Province immediately launched the "Level 1 Response" order for epidemic prevention and resistance. Within one hour after receiving the instructions from the provincial government, the company held a meeting of middle-level and above cadres to mobilize, deploy, draft and issue the company's "No. 18 Document", namely, the Notice on the Prevention of novel coronavirus. On January 28, the company also issued the "No. 21 Document", namely, the Notice on the Comprehensive Prevention and Control of novel coronavirus, and quickly set up a team with the general manager as the team leader and vice presidents in charge as the deputy team leaders The "Leading Group for Epidemic Prevention and Control Work" led by the Chief Financial Officer as the office director began an organized, implemented, inspected, and feedback campaign against the epidemic.
Thirdly, the workshop department has fully signed the commitment. The company also requires each employee to take the antiviral drug ribavirin capsules for more than a week to enhance their immune system. At the same time, all workshops, departments, branches, subsidiaries, and companies have fully signed the "Commitment Letter for Epidemic Prevention and Control". Subsequently, the company also issued the "Notice on Overtime Work and On duty Staff Taking Medicine", "Hygienic disinfection and sterilization Epidemic Prevention Measures", "Hot Light House Use Regulations" and other epidemic prevention and anti epidemic documents with the unique characteristics of "Cheng Yi Pharmaceutical" to guide the epidemic prevention work and production and operation "both hands, both hands must be hard".
The fourth is to carefully decide on the overtime system. After the outbreak of the epidemic, Yan Yiyi, the chairman and party secretary of the company, held a high sense of social responsibility and accumulated rich experience in the fight against SARS in 2003. After careful research and careful deployment with company executives, he decisively decided to organize more than 100 local employees in Dongtou to work overtime to produce ribavirin preparations in the preparation workshop and logistics, security, QA, QC, and logistics personnel on the third day of the Chinese New Year. As of February 14th, a total of 3.3 million injections were produced. Since February 5th, the country has included the star anti SARS drug ribavirin in the fifth, sixth, and seventh editions of the "Diagnosis and Treatment Plan for COVID-19".
After the outbreak of the epidemic, Chairman Yan Yiyi convened multiple video conferences with middle and senior cadres, clearly indicating that the production and operation tasks set at the beginning of the year for 2020 will remain unchanged and the performance will not decrease, and every effort should be made to ensure the healthy growth of various major economic indicators on the basis of last year. By mid March, the company's production had been at full capacity.
Reporter: Cheng Yi Pharmaceutical's experience of "focusing on epidemic prevention and promoting production" has received attention from all sectors of society. How will this promote the company's future development?
Zhao Chunjian: During the most severe period of the epidemic, in order to assist the epidemic area, Cheng Yi Pharmaceutical started construction ahead of schedule, worked overtime to produce antiviral drugs, donated anti epidemic materials to the Zhejiang Charity Federation and the Hubei Red Cross Society, and other charity activities. These activities have been reported by nearly a hundred domestic media outlets, including People's Daily, China News Network, Shanghai Securities News, Securities Times, Dazhong Securities News, Zhejiang News, Wenzhou Daily, etc, This has also established a good image of the company.
On February 6th, Wang Jiaohu, Secretary of the Dongtou District Committee, and Lin Xia, District Mayor, personally visited the company to express condolences to frontline employees who are working overtime to organize production, bringing warm care from the district committee and government. On February 8th, the company's party committee was rated as the first batch of "outstanding party organizations in epidemic prevention and control" by Wenzhou City. On February 15th, the company's "Youth Assault Team" was commended by the Wenzhou Municipal Committee of the Communist Youth League.
On February 5th and 6th, the company's stocks rose to the limit at the beginning of trading for two consecutive days. In securities media jargon, it is called "bullish bullish, with a promising future". I believe that the "Cheng Yi experience" summarized through this "one hand focus on epidemic prevention and one hand focus on production" will become a driving force, and all "Cheng Yi people" will build on this momentum to continue to create extraordinary performance, contribute all their strength to the high-quality development of the company and undertake more social responsibilities.
On February 20th, the company donated a batch of antiviral drugs to the Hubei Red Cross Society
Source of manuscript: Volkswagen Securities News